Vineet Kumar
Director: DP development and manufacturing at Spark Therapeutics/Roche
Over 20 years of end to end biologics (cell therapies, gene therapies, mAbs, bi-/trispecifics, fusion proteins, vaccines, batceriophages etc.) drug product development and manufacturing experience. Currently leading Spark’s (Roche, Gene therapy center of excellence) DP development and manufacturing efforts.
GENAP Summit is a brand owned by EPM Group, registered company in Portugal. EU VAT ID PT513501312